Deltanoid Pharmaceuticals
Latest round
- Series B
Last raised
- Dec 2007
Total raised
- $12M
Investors
- 3
About Deltanoid Pharmaceuticals
Deltanoid Pharmaceuticals is focused on pharmaceutical innovations, with its headquarters located in Madison, US.The primary offering of Deltanoid Pharmaceuticals is innovative pharmaceutical products aimed at providing effective healthcare solutions. Their product line addresses various therapeutic areas, targeting healthcare providers and patients seeking advanced treatment options.Deltanoid Pharmaceuticals operates with a revenue model focused on the sale of its pharmaceutical products, with structured pricing that accommodates various market segments. The company is targeting the North American and European markets for expansion, with initiatives set to launch by the end of 2023.
Who invested in Deltanoid Pharmaceuticals
3 investors across 1 round
See all investors in Deltanoid Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Dec 17, 2007
Amount
$12M
Investors
Questions about Deltanoid Pharmaceuticals
Who invested in Deltanoid Pharmaceuticals?
Deltanoid Pharmaceuticals has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Deltanoid Pharmaceuticals raised?
Deltanoid Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Deltanoid Pharmaceuticals last raise money?
Deltanoid Pharmaceuticals's most recent round on record is a Series B, in Dec 2007.
What does Deltanoid Pharmaceuticals do?
Deltanoid Pharmaceuticals is focused on pharmaceutical innovations, with its headquarters located in Madison, US.
Where is Deltanoid Pharmaceuticals headquartered?
Deltanoid Pharmaceuticals is headquartered in Madison, US.
Which VCs invest in companies like Deltanoid Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Deltanoid Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Deltanoid Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.